- Home
- WLKP vs BBNX Comparison
WLKP vs BBNX Comparison
Compare WLKP & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- BBNX
- Stock Information
- Founded
- WLKP 2014
- BBNX 2015
- Country
- WLKP United States
- BBNX United States
- Employees
- WLKP N/A
- BBNX N/A
- Industry
- WLKP Major Chemicals
- BBNX Medical/Dental Instruments
- Sector
- WLKP Industrials
- BBNX Health Care
- Exchange
- WLKP Nasdaq
- BBNX Nasdaq
- Market Cap
- WLKP 817.5M
- BBNX 866.3M
- IPO Year
- WLKP 2014
- BBNX 2025
- Fundamental
- Price
- WLKP $22.84
- BBNX $10.00
- Analyst Decision
- WLKP
- BBNX Strong Buy
- Analyst Count
- WLKP 0
- BBNX 6
- Target Price
- WLKP N/A
- BBNX $26.67
- AVG Volume (30 Days)
- WLKP 22.2K
- BBNX 670.0K
- Earning Date
- WLKP 04-30-2025
- BBNX 05-06-2025
- Dividend Yield
- WLKP 8.13%
- BBNX N/A
- EPS Growth
- WLKP 14.91
- BBNX N/A
- EPS
- WLKP 1.77
- BBNX N/A
- Revenue
- WLKP $1,135,896,000.00
- BBNX $65,123,999.00
- Revenue This Year
- WLKP $8.90
- BBNX $29.49
- Revenue Next Year
- WLKP $6.87
- BBNX $34.93
- P/E Ratio
- WLKP $13.10
- BBNX N/A
- Revenue Growth
- WLKP N/A
- BBNX 442.93
- 52 Week Low
- WLKP $21.19
- BBNX $10.63
- 52 Week High
- WLKP $25.04
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- WLKP 37.72
- BBNX N/A
- Support Level
- WLKP $23.00
- BBNX N/A
- Resistance Level
- WLKP $23.45
- BBNX N/A
- Average True Range (ATR)
- WLKP 0.32
- BBNX 0.00
- MACD
- WLKP -0.00
- BBNX 0.00
- Stochastic Oscillator
- WLKP 13.48
- BBNX 0.00
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet.